BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28279717)

  • 21. Yes-associated protein and WW-containing transcription regulator 1 regulate the expression of sex-determining genes in Sertoli cells, but their inactivation does not cause sex reversal.
    Levasseur A; Paquet M; Boerboom D; Boyer A
    Biol Reprod; 2017 Jul; 97(1):162-175. PubMed ID: 28637242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hippo Pathway Regulation by Tyrosine Kinases.
    Reuven N; Shanzer M; Shaul Y
    Methods Mol Biol; 2019; 1893():215-236. PubMed ID: 30565137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease.
    Wang K; Degerny C; Xu M; Yang XJ
    Biochem Cell Biol; 2009 Feb; 87(1):77-91. PubMed ID: 19234525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stem cell regulation by the Hippo pathway.
    Hiemer SE; Varelas X
    Biochim Biophys Acta; 2013 Feb; 1830(2):2323-34. PubMed ID: 22824335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of mechanotransduction via YAP/TAZ in animal epithelia.
    Elbediwy A; Thompson BJ
    Curr Opin Cell Biol; 2018 Apr; 51():117-123. PubMed ID: 29477107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications of the Hippo-YAP pathway in multiple cancer contexts.
    Kim HB; Myung SJ
    BMB Rep; 2018 Mar; 51(3):119-125. PubMed ID: 29366445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YAP and TAZ Take Center Stage in Cancer.
    Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W
    Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of Hippo Signaling Pathway in Lung Cancer].
    Liu Y; Xing Y; Cai L
    Zhongguo Fei Ai Za Zhi; 2017 Sep; 20(9):629-634. PubMed ID: 28935017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Mediated Approaches to Regulate YAP/TAZ Levels.
    Quinton RJ; Ganem NJ
    Methods Mol Biol; 2019; 1893():203-214. PubMed ID: 30565136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.
    Li X; Liu Y; Zhang C; Niu Q; Wang H; Che C; Xie M; Zhou B; Xu Y; Zhang Q; Wu J; Tian Z
    Oncotarget; 2017 Mar; 8(10):16356-16366. PubMed ID: 28099921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
    Nguyen HT; Kugler JM; Cohen SM
    PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The regulatory mechanisms and functional roles of the Hippo signaling pathway in breast cancer.
    Yao CB; Zhou X; Chen CS; Lei QY
    Yi Chuan; 2017 Jul; 39(7):617-629. PubMed ID: 28757476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck.
    Santos-de-Frutos K; Segrelles C; Lorz C
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.
    Sudol M
    Sci Signal; 2014 Dec; 7(355):pe29. PubMed ID: 25492964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway.
    Zhang J; Smolen GA; Haber DA
    Cancer Res; 2008 Apr; 68(8):2789-94. PubMed ID: 18413746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intersection of Hippo/YAP and Wnt/β-catenin signaling pathways.
    Konsavage WM; Yochum GS
    Acta Biochim Biophys Sin (Shanghai); 2013 Feb; 45(2):71-9. PubMed ID: 23027379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Hippo-YAP signaling pathway and contact inhibition of growth.
    Gumbiner BM; Kim NG
    J Cell Sci; 2014 Feb; 127(Pt 4):709-17. PubMed ID: 24532814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
    Santoro R; Zanotto M; Carbone C; Piro G; Tortora G; Melisi D
    Anticancer Res; 2018 Apr; 38(4):1937-1946. PubMed ID: 29599309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
    Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
    J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining the Phosphorylation Status of Hippo Components YAP and TAZ Using Phos-tag.
    Chen R; Plouffe SW; Guan KL
    Methods Mol Biol; 2019; 1893():281-287. PubMed ID: 30565141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.